Royalty Pharma
- Check size
- ~$50M–$300M (est.)Estimated — modeled from this fund's AUM or comparable lenders, not confirmed by the fund. Counts for less than a confirmed range in match scoring.
- Structures
- Senior
- Sectors
- Healthcare
- Geographies
- Global
- Headquarters
- New York, United States
Team
Deal-team contacts
Deal-team contacts are not sold on this site. A TerraNova Capital Partners banker can coordinate an approach to Royalty Pharma as part of a written advisory engagement.
Profile and contact information is compiled from public and licensed sources and TerraNova Capital Partners' own research. It is not provided or endorsed by the fund, and accuracy is not guaranteed.
About
Specialty finance. Products: royalty acquisitions, synthetic royalties, senior secured term loans.
Recent activity
Up to $2B funding deal with Revolution Medicines incl. $750M senior secured loan (Jun 2025)
Similar funds
Compare side by side →- $10K–$20Munconfirmed
- ~$3M–$25M (est.)
- $5K–$5Munconfirmed